| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/26/2009 | US20090054496 N-[o-(cyclopropylcyclobutyl)phenyl]heterocyclecarboxamides, for use in agriculture or horticulture for controlling or preventing infestations of plants by phytopathogenic microorganisms, especially fungi. |
| 02/26/2009 | US20090054448 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 02/26/2009 | US20090054438 Compositions and methods for inhibiting growth and metastasis of melanoma |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054379 7-Pyrollyl 9-Aminoacyl Tetracycline Compounds and Methods of Use Thereof |
| 02/26/2009 | US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers |
| 02/26/2009 | US20090053721 Voltage-gated ion channel mutants for use in identifying ion channel modulating compounds |
| 02/26/2009 | CA2697325A1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/26/2009 | CA2697256A1 Cyclopropyl amide derivatives |
| 02/26/2009 | CA2696429A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity |
| 02/25/2009 | EP2028185A1 Tubulysin and tubulysin agent |
| 02/25/2009 | EP2027087A2 Intracellular kinase inhibitors |
| 02/25/2009 | EP2027086A2 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 02/25/2009 | EP1701939B1 Anthraquinone compounds as anti cancer compounds |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN101374807A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 02/25/2009 | CN101372475A Aromatic heterocyclic substituted acardite derivative and use thereof |
| 02/25/2009 | CN101372473A Preparation of N-hydroxy diimide |
| 02/25/2009 | CN101372472A Method for synthesizing Zofenopril |
| 02/24/2009 | US7495023 treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis; also inhibiting cathepsins B and L to treat cancer; e.g. 3'-Bromopropiophenone Thiosemicarbazone |
| 02/24/2009 | US7495022 α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| 02/24/2009 | US7495016 inhibiting HIV replication in a cell; inhibiting reverse transcriptase |
| 02/24/2009 | US7495012 Arylsulfonamides and uses related thereto |
| 02/24/2009 | US7494987 compounds with potent antitussive actions, high safety and less adverse actions; methyl 4-({1-[2-(4-cyanophenyl)ethyl]-3-hydroxyazetidin-3-ylmethyl}methylamino)benzoate |
| 02/24/2009 | CA2417361C New phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 02/24/2009 | CA2219455C Use of pyrrolidine derivatives for treating alcoholism |
| 02/19/2009 | WO2009023260A2 An improved process for synthesis of pyrrole derivative, an intermediate for atorvastatin |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022168A1 Novel crystalline form |
| 02/19/2009 | WO2009021946A1 Novel compounds |
| 02/19/2009 | WO2009021945A1 New compounds |
| 02/19/2009 | WO2009021758A1 Arylsulfonamides having an analgesic effect |
| 02/19/2009 | WO2009021589A1 Tyrosinase inhibitors |
| 02/19/2009 | US20090048454 Process for Producing Aminoacetyl Pyrrolidine Carbonitrile Derivative and Intermediate for Production Thereof |
| 02/19/2009 | US20090048453 Crystalline form of atorvastatin sodium or its hydrate; use treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's Disease |
| 02/19/2009 | US20090048330 Compound from Antrodia camphorata and the use thereof |
| 02/19/2009 | US20090048329 Substituted Pyrrolidine Compounds With Central Nervous System Activity |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090047224 Cosmetic Process for Preventing or Treating the Signs of Skin Ageing or the Orange-Peel Appearance |
| 02/19/2009 | US20090045373 Compounds, ionic liquids, molten salts and uses thereof |
| 02/19/2009 | DE102007038097A1 Tyrosinaseinhibitoren Tyrosinase |
| 02/19/2009 | DE102007037017A1 1-Alkyl-5-oxo-pyrrolidin-3-carbonsäureester mit verbesserter biologischer Abbaubarkeit 1-alkyl-5-oxo-pyrrolidine-3-carboxylic acid ester having improved biodegradability |
| 02/19/2009 | CA2696556A1 New compounds |
| 02/19/2009 | CA2696349A1 Heterocyclic inhibitors of necroptosis |
| 02/19/2009 | CA2696302A1 New compounds |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2694835A1 Novel crystalline form |
| 02/18/2009 | EP2025696A1 Method for producing curing agent having acidic substituent and unsaturated maleimide group, thermosetting resin composition, prepreg, and laminate |
| 02/18/2009 | EP2025679A2 [3.2.0] Heterocyclic compounds and methods of using the same |
| 02/18/2009 | EP2025675A1 Arylsulfonamides with analgetic activity |
| 02/18/2009 | EP2025668A1 Arylsulfonamides with analgetic activity |
| 02/18/2009 | EP2024331A1 Crystalline form of atorvastatin calcium stable after storage |
| 02/18/2009 | EP2024330A1 Production method of heterocyclic mercapto compound |
| 02/18/2009 | EP1513519B1 The use of substituted cyanopyrrolidines for treating hyperlipidemia |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | CN101370792A Bi-aryl meta-pyrimidine inhibitors of kinases |
| 02/18/2009 | CN101370774A Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 02/18/2009 | CN101367839A Preparation method for fosinopril and its salt |
| 02/18/2009 | CN101367757A Preparation method for (S)-4-hydroxyl-2-oxo-1-pyrrolidine ethanamide |
| 02/18/2009 | CN101367748A Amide derivatives, process for production of the same, and method for application thereof as insecticide |
| 02/17/2009 | US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491724 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | CA2257010C Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 02/12/2009 | WO2009020234A2 Pyrrolidin-2 -one derivatives as androgen receptor modulator |
| 02/12/2009 | WO2009020140A1 Adamantylurea derivative |
| 02/12/2009 | WO2009019566A1 Phenoxy-pyrrolidine derivative and its use and compositions |
| 02/12/2009 | WO2008155334A3 Improved process of amide formation |
| 02/12/2009 | WO2008152260A3 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 02/12/2009 | WO2008139481A3 Proton acceptor iminium/carbocation-type coupling agents |
| 02/12/2009 | WO2007086054A3 A process for preparing allylmercaptocaptopril (cpssa) and related asymmetrical disulfides |
| 02/12/2009 | US20090043146 1-Alkyl-5-oxopyrrolidine-3-carboxylic esters with improved biodegradability |
| 02/12/2009 | US20090043099 Methods and compositions for derepression of IAP-inhibited caspase |
| 02/12/2009 | US20090042967 androgen receptor modulators; specific pyrrolidinone-functional benzonitrile compounds such as 2-Chloro-4-[4-hydroxy-5-methyl-2-oxopyrrolidin-1-yl]benzonitrile or 2-Chloro-4-[5-ethyl-3,3-difluoro-4-hydroxy-2-oxopyrrolidin-1-yl]benzonitrile |
| 02/12/2009 | US20090042942 Muscarinic Receptor Antagonists |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042907 Bicyclic aromatic sulfinyl derivatives |
| 02/12/2009 | US20090042896 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 02/12/2009 | US20090042262 Preparation of Pregabalin and Related Compounds |
| 02/12/2009 | US20090042041 Pyrrolyl complexes of copper for copper metal deposition |
| 02/12/2009 | US20090041721 Arylalkoxyl hepatitis c virus protease inhibitors |
| 02/12/2009 | US20090039771 Organic electroluminescent element material, organic electroluminescent element, display device and lighting device |
| 02/12/2009 | CA2695852A1 Cyclic amine compounds |
| 02/12/2009 | CA2695664A1 Phenoxy-pyrrolidine derivative and its use and compositions |
| 02/12/2009 | CA2666246A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 02/11/2009 | EP2022781A1 1-Alkyl-5-oxo-pyrrolidine-3-carboxylic acid esters with improved biodegradability |
| 02/11/2009 | EP2021345A1 Hydroxylated amide skin moisturizer |
| 02/11/2009 | EP2021337A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 02/11/2009 | EP2021336A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 02/11/2009 | EP2021334A1 Synthesis and uses of pyroglutamic acid derivatives |
| 02/11/2009 | EP1241986B1 Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
| 02/11/2009 | CN101365677A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 02/11/2009 | CN101365493A Keratin-binding effector molecules, and method for the production thereof |